US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bemis

57.25

0.0000

Volume:- -

Turnover:- -

Market Cap:5.22B

PE:22.68

High:57.25

Open:57.25

Low:57.25

Close:57.25

52wk High:59.85

52wk Low:40.86

Shares:91.21M

Float Shares:90.29M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.52

EPS(LYR):2.48

ROE:--

ROA:--

PB:4.18

PE(LYR):23.08

Loading ...

Overview Company News Filings

Prothena says partner Bristol Myers Squibb’ BMS-986446 granted FDA fast-track

After Frozen Shrimp, Radioactive Traces Also Found in Indonesia's Exported Cloves

Braemar Shipping Services (BMS) Receives a Buy from Canaccord Genuity

Press Release: Flux Power Closes $5 Million Private Placement of Prefunded Warrants and Common Warrants

Qinjie Electronics Pursues Hong Kong IPO: Capital Market Strategy of Leading Automotive-Grade Wireless Sensor Company

Rumors of BMS Divesting Core China Business, Hillhouse Capital to Take Over

Sichuan's New Richest Person Emerges as Company Market Value Exceeds 150 Billion Yuan

Flux Power to Host Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call on September 16, 2025

Flux Power and Averest to Showcase Energy Management and Software Solutions for GSE at the International GSE Expo 2025 in Las Vegas

Press Release: Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor

Flux Power to Participate at Upcoming Financial Conferences

Southchip Semiconductor's BMS Evolution Logic Through Technological Innovation

Press Release: Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates

Flux Power Awarded New Patent for Predictive Quantum Balancing

Flux Power Recognized Among Financial Times’ Fastest Growing Companies in the Americas 2025

Press Release: Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer

KULR CEO Michael Mo to Speak at Strategy World 2025

Press Release: Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BMS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMS\",,,,,undefined,":{"symbol":"BMS","market":"US","secType":"STK","nameCN":"Bemis","latestPrice":57.25,"timestamp":1569009600000,"preClose":57.25,"halted":0,"volume":0,"delay":0,"floatShares":90294980,"shares":91211990,"eps":2.5238,"marketStatus":"Post-Mkt","change":0,"latestTime":"10-03 16:30:46 EDT","open":57.25,"high":57.25,"low":57.25,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.5238,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1759536000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":57.25,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMS\",,,,,undefined,":{"symbol":"BMS","floatShares":90294980,"roa":"--","roe":"--","lyrEps":2.480219,"shares":91211990,"dividePrice":0,"high":57.25,"amplitude":0,"preClose":57.25,"low":57.25,"week52Low":40.86,"pbRate":"4.18","week52High":59.85,"institutionHeld":0.7014,"latestPrice":57.25,"eps":2.5238,"divideRate":0,"volume":0,"delay":0,"ttmEps":2.5238,"open":57.25,"prevYearClose":57.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-01-29","symbol":"BMS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1580274000000,"reportTimeType":"pre","actualEps":null},{"date":"2019-10-23","symbol":"BMS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1571817600000,"name":null,"time":"Pre-Market","dateTimestamp":1571803200000,"actualEps":null},{"market":"US","date":"2019-04-26","symbol":"BMS","amount":0.32,"name":"碧美斯","payableDate":"2019-04-29","currency":"USD","type":"dividend","dateTimestamp":1556251200000},{"market":"US","date":"2019-04-22","symbol":"BMS","fiscalQuarterEnding":"2019/03","expectedEps":0.66,"name":null,"time":"","type":"earning","dateTimestamp":1555905600000,"reportTimeType":"","actualEps":0.67},{"market":"US","date":"2019-02-19","symbol":"BMS","amount":0.32,"name":"碧美斯","currency":"USD","type":"dividend","dateTimestamp":1550552400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMS\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-16","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-05-15","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-08-15","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-11-14","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2018-02-16","recordDate":null,"paymentDate":null,"value":0.31,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2572755005","title":"Prothena says partner Bristol Myers Squibb’ BMS-986446 granted FDA fast-track","url":"https://stock-news.laohu8.com/highlight/detail?id=2572755005","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572755005?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:55","pubTimestamp":1759352120,"startTime":"0","endTime":"0","summary":"Prothena (PRTA) “announced that Bristol Myers Squibb (BMY) communicated in a press release that the U.S. Food and Drug Administration has granted F...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prothena-says-partner-bristol-myers-squibb-bms-986446-granted-fda-fast-track-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prothena-says-partner-bristol-myers-squibb-bms-986446-granted-fda-fast-track-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242652126.USD","BMS","LU0306806265.USD","LU0985481810.HKD","LU1868836757.USD","LU1868837300.USD","LU2125154935.USD","LU1989771016.USD","LU1093756168.USD","LU2360032135.SGD","LU1291159041.SGD","IE0009355771.USD","LU1868836914.USD","IE00B2B36J28.USD","LU0225771236.USD","LU1571399168.USD","LU1074936037.SGD","IE00BJT1NW94.SGD","LU1261432733.SGD","BK4007","IE0002141913.USD","IE00BJJMRZ35.SGD","LU1032466523.USD","BK4581","LU1868837136.USD","BK4588","LU0456855351.SGD","BK4585","LU0868494617.USD","LU1670710661.SGD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","BK4559","LU1585245621.USD","LU0225284248.USD","IE00BFXG1179.USD","LU2242646821.SGD","LU0882574055.USD","LU0267386448.USD","BMY","LU0321505439.SGD","LU0096364046.USD","LU1670710588.SGD","LU1670711123.USD","LU0061475181.USD","LU1093756325.SGD","LU1868836591.USD","PRTA","BK4534","LU2133065610.SGD"],"gpt_icon":0},{"id":"2572105583","title":"After Frozen Shrimp, Radioactive Traces Also Found in Indonesia's Exported Cloves","url":"https://stock-news.laohu8.com/highlight/detail?id=2572105583","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572105583?lang=en_us&edition=fundamental","pubTime":"2025-10-01 12:37","pubTimestamp":1759293431,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Traces of radionuclide Cesium 137  were found earlier in the frozen shrimp products of PT Bahari Makmur Sejati  in the Cikande industrial area. Bara Krishna Hasibuan, an expert staff member of the Coordinating Ministry for Food Affairs, mentioned that traces of the substance are also found in one of the spice export commodities, cloves.Bara said the Task Force for Handling the Hazards of Radioactive Cesium 137 is still investigating the origins of the contamination affecting the cloves. \"Over the past few days, we received reports from the United States. It turns out that the clove products are also contaminated,\" Bara said after a coordination meeting at the Graha Mandiri in Central Jakarta on Tuesday, September 30, 2025.Bara said the government is anticipating all possible consequences of the Cs-137 contamination, hoping that no other commodities will be tainted. \"We are working swiftly to localize the source of the contamination . The location has been declareda ","market":"other","thumbnail":"https://statik.tempo.co/data/2025/09/11/id_1427656/1427656_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/09/11/id_1427656/1427656_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2053319/after-frozen-shrimp-radioactive-traces-also-found-in-indonesias-exported-cloves","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2053319/after-frozen-shrimp-radioactive-traces-also-found-in-indonesias-exported-cloves","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BMS","BK4166","PMT.AU","PT","BK4110","PMT","BK7095"],"gpt_icon":0},{"id":"2570090205","title":"Braemar Shipping Services (BMS) Receives a Buy from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2570090205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570090205?lang=en_us&edition=fundamental","pubTime":"2025-09-25 20:55","pubTimestamp":1758804926,"startTime":"0","endTime":"0","summary":"In a report released today, from Canaccord Genuity reiterated a Buy rating on Braemar Shipping Services, with a price target of p320.00. The compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/braemar-shipping-services-bms-receives-a-buy-from-canaccord-genuity-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/braemar-shipping-services-bms-receives-a-buy-from-canaccord-genuity-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMS"],"gpt_icon":0},{"id":"2567107115","title":"Press Release: Flux Power Closes $5 Million Private Placement of Prefunded Warrants and Common Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2567107115","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567107115?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:31","pubTimestamp":1758025860,"startTime":"0","endTime":"0","summary":"VISTA, Calif., Sept. 16, 2025  -- Flux Power Holdings, Inc. , a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today announced that it has entered into securities purchase agreements for the sale of an aggregate of 258,144 Prefunded Warrants and 1,214,769 Common Warrants for gross proceeds of approximately $5.0 million, before deducting offering expenses, and is expected to be used for working capital and general corporate purposes. The purchase price was paid in cash or, in lieu of cash, cancellation of certain existing debt by the Company.Each Prefunded Warrant entitles the holder to purchase one  share of the Company's Series A Convertible Preferred Stock, par value $0.001 per share, or the Series A Preferred Stock, for $0.001 per share. Purchasers of Prefunded Warrants were also issued an additional five  year Common Warrant to purchase a number of shares of common stock equal to fifty ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMS","BK4096","BK4234","BK4084","FLUX","PW"],"gpt_icon":0},{"id":"1177584559","title":"Qinjie Electronics Pursues Hong Kong IPO: Capital Market Strategy of Leading Automotive-Grade Wireless Sensor Company","url":"https://stock-news.laohu8.com/highlight/detail?id=1177584559","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177584559?lang=en_us&edition=fundamental","pubTime":"2025-09-16 16:41","pubTimestamp":1758012070,"startTime":"0","endTime":"0","summary":"On September 5, 2025, Qinjie Electronics Technology (Jiangsu) Co., Ltd., a manufacturer of automotive wireless sensor SoCs (System-on-Chip), officially submitted its prospectus to the Hong Kong Stock...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861219969.SGD","BMS","LU0724618433.USD","LU0348723411.USD","LU2298322129.HKD","BK4141","LU2357305700.SGD","LU1861214812.USD","LU1854103824.USD","LU1861220033.SGD","BK4585","LU2360107325.USD","USI","LU1861215975.USD","LU1720051017.SGD","LU1720051108.HKD","IE00BD6J9T35.USD","LU1854104046.USD","BK4588","IE00BZ199S13.USD","LU1548497426.USD","LU1978683503.SGD","ON","LU0124384867.USD","BK4512","BK4605"],"gpt_icon":0},{"id":"1174900738","title":"Rumors of BMS Divesting Core China Business, Hillhouse Capital to Take Over","url":"https://stock-news.laohu8.com/highlight/detail?id=1174900738","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174900738?lang=en_us&edition=fundamental","pubTime":"2025-09-12 20:01","pubTimestamp":1757678491,"startTime":"0","endTime":"0","summary":"A rumor circulating within the industry today suggests that Bristol-Myers Squibb (BMS) China operations may undergo significant restructuring. According to purported email content, BMS has signed an...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0650527681.SGD","LU0164865239.USD","LU0320764755.SGD","LU1813983027.USD","LU0140636845.USD","LU0348825331.USD","LU1282649067.USD","LU0488056044.USD","LU2257852520.SGD","LU0345775950.USD","LU0370786039.SGD","LU1044874839.SGD","LU1366334651.USD","IE0032431581.USD","LU0164880469.USD","LU0315179316.USD","LU1251922891.USD","JD","BK1615","LU1282651048.USD","BK1502","LU0149721374.USD","LU1794554557.SGD","LU0052750758.USD","LU1224444064.USD","LU0231483743.USD","LU0572944931.SGD","LU2242644610.SGD","LU0499858602.USD","LU0228367735.SGD","BK1619","LU1303224171.USD","LU1481107354.HKD","BK1610","LU0456827905.SGD","LU1642822792.SGD","BMS","SG9999001226.SGD","BK1588","LU0672654166.SGD","LU1808992512.USD","LU0048580855.USD","LU0456846285.SGD","LU0868486357.SGD","LU2039709279.SGD","89618","LU0431992006.USD","LU0543330483.HKD","LU0293314216.USD","LU1044876610.USD","LU0029875118.USD","BK1591","LU1770034418.SGD","09618","LU1720050803.USD","LU0708995583.HKD","LU1719994722.HKD","LU0588546209.SGD","LU0327786744.USD","LU0359201612.USD","LU0588545490.SGD","BK1575","LU0051755006.USD","LU1328277881.USD","LU0039217434.USD","LU1770036033.HKD","SG9999002828.SGD","LU0588545730.USD","LU0359201885.HKD","LU0791590937.USD","LU0531971595.HKD","LU1282649810.SGD","LU0348735423.USD","SG9999002562.SGD","LU0469268626.HKD","LU0871576103.HKD","LU0084288322.USD","LU0128522157.USD","LU0499858438.USD","LU0865486749.SGD","LU0417516902.SGD","LU0345776255.USD","LU0259732245.USD","LU0314109678.HKD","LU0163747925.USD","LU0348805143.USD","LU0791591158.USD","LU1366334578.USD","BK1249","LU0588545904.SGD","LU0456842615.SGD","LU1282651121.HKD","IE00B29SXG58.USD","LU0828237510.HKD","LU0384037296.USD","IE00B3M56506.USD","BK1142","LU0417516738.SGD","LU0359202008.SGD","LU0211977185.USD","LU1044875133.USD","LU0307460666.USD","IE00BGV7N243.SGD","LU0594300419.USD","LU0315178854.USD","LU0228659784.USD","LU0320764599.SGD","LU1023057109.AUD"],"gpt_icon":1},{"id":"1196998549","title":"Sichuan's New Richest Person Emerges as Company Market Value Exceeds 150 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1196998549","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196998549?lang=en_us&edition=fundamental","pubTime":"2025-09-10 19:33","pubTimestamp":1757504022,"startTime":"0","endTime":"0","summary":"A single BD transaction has led to a dramatic surge in Bailitian Heng's performance. However, beneath the spotlight, concerns remain. Innovative drug R&D requires substantial investment with long...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BMS","399300","06978","BK1161","159982"],"gpt_icon":0},{"id":"2566697556","title":"Flux Power to Host Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call on September 16, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2566697556","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566697556?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:31","pubTimestamp":1757421060,"startTime":"0","endTime":"0","summary":"VISTA, Calif., Sept.  09, 2025  (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions for industrial applications, will rep","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/09/3146918/24114/en/Flux-Power-to-Host-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results-Conference-Call-on-September-16-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4096","BK4084","FLUX","BMS","BK4181","PW","BK4588","BK4234","HST","BK4218","BK4585"],"gpt_icon":0},{"id":"2564740703","title":"Flux Power and Averest to Showcase Energy Management and Software Solutions for GSE at the International GSE Expo 2025 in Las Vegas","url":"https://stock-news.laohu8.com/highlight/detail?id=2564740703","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564740703?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:31","pubTimestamp":1756989060,"startTime":"0","endTime":"0","summary":"Flux Power and Averest to showcase integrated energy management solutions at the International GSE Expo, highlighting innovations that drive efficiency, sustainability, and smarter ground support oper","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/04/3144535/24114/en/Flux-Power-and-Averest-to-Showcase-Energy-Management-and-Software-Solutions-for-GSE-at-the-International-GSE-Expo-2025-in-Las-Vegas.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4234","PW","BMS","BK4084","FLUX","BK4096"],"gpt_icon":0},{"id":"2564396930","title":"Press Release: Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor","url":"https://stock-news.laohu8.com/highlight/detail?id=2564396930","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564396930?lang=en_us&edition=fundamental","pubTime":"2025-09-03 21:05","pubTimestamp":1756904700,"startTime":"0","endTime":"0","summary":"SAN DIEGO and SUZHOU, China, Sept. 03, 2025  -- Adagene Inc.  , a company transforming the discovery and development of antibody-based therapies, today announced the appointment of Dr. Axel Hoos as Executive Advisor.Dr. Hoos received his M.D. in Medicine from Heidelberg University, and his Ph.D. in Molecular Oncology from the German Cancer Research Center . He trained in general surgery at the Technical University of Munich and as a fellow in cancer research at Memorial Sloan-Kettering Cancer Center and is an alumnus of the Program for Leadership Development at Harvard Business School.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4588","BK4585","R","CRC","03160","LU0266512127.USD","TM","BK4139","ADAG","BMS","BK4099","BK4232","LU0456854461.SGD","BK4213","BK4604","BK4555","BK4113","MSS"],"gpt_icon":0},{"id":"2562220787","title":"Flux Power to Participate at Upcoming Financial Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2562220787","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562220787?lang=en_us&edition=fundamental","pubTime":"2025-08-26 04:05","pubTimestamp":1756152300,"startTime":"0","endTime":"0","summary":"VISTA, Calif., Aug.  25, 2025  (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions for industrial applications, today ann","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/25/3138851/24114/en/Flux-Power-to-Participate-at-Upcoming-Financial-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMS","FLUX","PW","BK4084","BK4234","BK4096"],"gpt_icon":0},{"id":"1137926879","title":"Southchip Semiconductor's BMS Evolution Logic Through Technological Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=1137926879","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137926879?lang=en_us&edition=fundamental","pubTime":"2025-08-15 10:42","pubTimestamp":1755225741,"startTime":"0","endTime":"0","summary":"In today's era of accelerated consumer electronics iteration and continuously expanding new energy application scenarios, batteries serve as core energy carriers, with their safety, energy...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0214","BMS","BK0231","688484"],"gpt_icon":0},{"id":"2558498626","title":"Press Release: Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2558498626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558498626?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:00","pubTimestamp":1754996400,"startTime":"0","endTime":"0","summary":"Trial of Budoprutug in Primary Membranous Nephropathy  Expected to Initiate in the Coming Weeks. Budoprutug Subcutaneous Formulation Demonstrated High Bioavailability and Favorable Tolerability in Non-clinical Studies;Phase 1 Trial Expected to Initiate in the Coming Weeks, with Initial Data Anticipated in First Half 2026. CLYM116 Focused Webcast Event, Including New Preclinical Data, Planned for September 2025;IND or CTA Submission for IgA Nephropathy  Expected in Second Half 2025. Strong Financial Position, with Cash Runway Expected Through 2027. WELLESLEY HILLS, Mass., Aug. 12, 2025  -- Climb Bio, Inc. , a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today reported financial results for the second quarter ended June 30, 2025 and provided business updates.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BMS","CTA","BK4139","BK4077","ITP","BK4199","CLYM","SLE"],"gpt_icon":0},{"id":"2557394704","title":"Flux Power Awarded New Patent for Predictive Quantum Balancing","url":"https://stock-news.laohu8.com/highlight/detail?id=2557394704","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557394704?lang=en_us&edition=fundamental","pubTime":"2025-08-05 20:31","pubTimestamp":1754397060,"startTime":"0","endTime":"0","summary":"Patent covers a breakthrough approach to battery charge balancing technology to optimize performance, extend battery life, and reduce downtime.VISTA, Calif., Aug.  05, 2025  (GLOBE NEWSWIRE) -- Flux P","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/05/3127381/24114/en/Flux-Power-Awarded-New-Patent-for-Predictive-Quantum-Balancing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMS","FLUX","PW","BK4084","BK4234","BK4096","TCO"],"gpt_icon":0},{"id":"2553561592","title":"Flux Power Recognized Among Financial Times’ Fastest Growing Companies in the Americas 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2553561592","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553561592?lang=en_us&edition=fundamental","pubTime":"2025-07-22 21:00","pubTimestamp":1753189200,"startTime":"0","endTime":"0","summary":"Inclusion on the FT list reflects strong customer adoption of lithium-ion energy solutions and continued market expansion across industrial sectorsVISTA, Calif., July  22, 2025  (GLOBE NEWSWIRE) -- Fl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/22/3119485/24114/en/Flux-Power-Recognized-Among-Financial-Times-Fastest-Growing-Companies-in-the-Americas-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PW","FLUX","BK4084","BMS","BK4096","BK4234"],"gpt_icon":0},{"id":"2544149979","title":"Press Release: Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2544149979","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544149979?lang=en_us&edition=fundamental","pubTime":"2025-06-18 19:00","pubTimestamp":1750244400,"startTime":"0","endTime":"0","summary":"Dr. Charles, Accomplished Immunology-Focused Drug Developer, Brings More Than 20 years of Biopharma Leadership, Clinical Development, and Operations Expertise. Company Also Hires Cindy J. Driscoll, MBA, Financial Executive with Over Two Decades of Experience Guiding Biotechnology Companies, as Senior Vice President, Finance. WELLESLEY HILLS, Mass., June 18, 2025  -- Climb Bio, Inc. , a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced the appointments of Edgar D. Charles, M.D., MSc as its Chief Medical Officer  and Cindy J. Driscoll, MBA as Senior Vice President, Finance.Dr. Charles holds a Doctor of Medicine from the University of Alabama School of Medicine, a Master of Science in Clinical and Translational Investigation from Rockefeller University, and a Bachelor of Arts in Economics from the University of Chicago. He completed his Internal Medicine residency and Infectious Diseases fellowship at N","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CLYM","BMS"],"gpt_icon":0},{"id":"2526263566","title":"KULR CEO Michael Mo to Speak at Strategy World 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2526263566","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526263566?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:30","pubTimestamp":1744288200,"startTime":"0","endTime":"0","summary":"Silver Sponsorship will support AI and Bitcoin focused conference hosted by Strategy HOUSTON, April  10, 2025  (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the \"Company\" or \"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/10/3059241/0/en/KULR-CEO-Michael-Mo-to-Speak-at-Strategy-World-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4594","BK4588","STRK","09439","KULR","03008","BMS","BK4600","BK4096","83042","09042","09008","03439","BK4601","BK4023","BK1611","MSTR","BK4516","BK4595","03042","BK4596"],"gpt_icon":1},{"id":"2526384049","title":"Press Release: Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2526384049","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526384049?lang=en_us&edition=fundamental","pubTime":"2025-04-09 04:05","pubTimestamp":1744142700,"startTime":"0","endTime":"0","summary":"Dr. Banerjee's appointment culminates Artiva's efforts to build a seasoned development team with strong expertise in autoimmune diseases and cell therapy. Dr. Banerjee added, \"Artiva is leading the development of NK cell treatments for autoimmune disease, with the potential to offer a much-needed, long-term therapeutic option with an accessibility and safety profile that enables broad use in a community setting. The robust B-cell depletion seen with AlloNK through enhanced antibody-directed killing of cells in non-Hodgkin lymphoma bodes well for our opportunity to deeply deplete B-cells in patients with autoimmune diseases and to bring about meaningful clinical improvements and medication reductions. Artiva has built a very seasoned development team, and I am excited to lead the effort to further define the indications where AlloNK can be most impactful, and to help drive the program towards late-stage development.\"","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IIM","RA","BK4139","ARTV","BMS","SLE","R","BK4232","BK4022","BK4077"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}